About Kappa Bioscience
Kappa Bioscience is a Healthcare company based in Oslo (Norway) founded in 2006, and was acquired by Balchem in June 2022. Provider of nutraceutical and vitamin ingredients. The company has 42 employees. Its chief executive, as recorded, is Egil Greve. Kappa Bioscience offers products and services including K2VITALâ„¢ and K2VITALâ„¢ DELTA. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Vitamins. Its legal entity is Balchem Corporation.
Company details
Kappa Bioscience was founded in 2006 in Oslo, Norway, as a provider in the nutraceutical sector. Ingredients and related services are offered, with a focus on bone and heart health applications. The primary product, vitamin K2 in the form of menaquinone-7 (MK-7), is supplemented by vitamin D3 and plant-derived calcium citrate. Operations center on ingredient development and supply within the health supplement industry.
- Headquarters Oslo, Norway
- Employees 42
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kappabio.com
- Social LinkedIn X
- Acquired by Balchem (Jun 2022)
- Legal Name Balchem Corporation
Products & Services of Kappa Bioscience
Kappa Bioscience offers a comprehensive portfolio of products and services, including K2VITAL™ and K2VITAL™ DELTA.
Offers bioactive vitamin K2 for bone and heart health support.
Provides stable, microencapsulated vitamin K2 for formulations.
Investors in Kappa Bioscience
Kappa Bioscience has secured backing from 1 investor. Prominent investors backing the company include Balchem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Nutraceutical ingredients are manufactured for human and animal nutrition products. | 1967 | balchem.com | New Hampton, United States |
Investor details for Kappa Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kappa Bioscience
1 people are tracked at Kappa Bioscience (1 in leadership); the tracked headcount is 42.
| Name | Role | Group |
|---|---|---|
Egil Greve | CEO & President | Leadership |
Complete people profiles for Kappa Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kappa Bioscience
2 dated milestones of Kappa Bioscience across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Kappa Bioscience is founded.
- Exit Acquired by Balchem.
Web traffic of Kappa Bioscience
Websites that share an audience with Kappa Bioscience (kappabio.com).
Websites whose visitors overlap most with Kappa Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
advances.nutrition.org | advances.nutrition.org | 100% | – | ||
efsa.europa.eu | efsa.europa.eu | 100% | – | ||
| nutraingredients-usa.com | 100% | #11,120,428 | View details | ||
chriskresser.com | chriskresser.com | 100% | #548,125 | – | |
| purebio.com | 65% | 2.1K | #7,643,860 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Kappa Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kappa Bioscience
Complete news archive for Kappa Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kappa Bioscience
Kappa Bioscience was founded in 2006.
Kappa Bioscience is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Egil Greve is the CEO of Kappa Bioscience, as recorded in our data.
Kappa Bioscience has 42 employees.
Kappa Bioscience was founded in 2006 in Oslo, Norway, as a provider in the nutraceutical sector. Ingredients and related services are offered, with a focus on bone and heart health applications. The primary product, vitamin K2 in the form of menaquinone-7 (MK-7), is supplemented by vitamin D3 and plant-derived calcium citrate. Operations center on ingredient development and supply within the health supplement industry.
Kappa Bioscience offers K2VITALâ„¢ and K2VITALâ„¢ DELTA.
Kappa Bioscience has 1 investor. Key investors include Balchem.
Kappa Bioscience operates through Balchem Corporation.
Yes. Kappa Bioscience was acquired by Balchem in June 2022.